BeStock  

Elanco Animal 医疗 ELAN

美股市值排名 #1261药品制造-专科与仿制
$25.74 +$2.06 (+8.70%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $25.74 0.00%
开盘$24.07
昨收$23.68
当日区间$23.97 – $26.26
成交量11.51M
市值$12.86B
市盈率(TTM)–
股息率–

基本面

最新报告季度:Q2, ended Jun 2026

营收$1.37B+10.2% YoY
营业利润$118.00M+38.8% YoY
净利润$54.00M+390.9% YoY
摊薄每股收益$0.11+450.0% YoY
自由现金流$244.00M+35.6% YoY
经营现金流$277.00M

营收,近8个季度

$1.0BSep '24$1.0BDec '24$1.2BMar '25$1.2BJun '25$1.1BSep '25$1.1BDec '25$1.4BMar '26$1.4BJun '26

净利润,近8个季度

$364.0MSep '24$-8.0MDec '24$67.0MMar '25$11.0MJun '25$-34.0MSep '25$-276.0MDec '25$57.0MMar '26$54.0MJun '26

各季度摊薄每股收益

0.73Sep '24-0.02Dec '240.13Mar '250.02Jun '25-0.07Sep '25-0.56Dec '250.11Mar '260.11Jun '26

各季度自由现金流

$120.0MSep '24$130.0MDec '24$-69.0MMar '25$180.0MJun '25$127.0MSep '25$46.0MDec '25$-38.0MMar '26$244.0MJun '26

年度营收

$3.3BFY20$4.8BFY21$4.4BFY22$4.4BFY23$4.4BFY24$4.7BFY25

盈利能力与资产负债表

毛利率55.4%
营业利润率6.6%
净利率-4.0%
净资产收益率-3.0%
资产收益率-1.5%
投入资本回报率-0.5%
流动比率2.05
负债/资产比率51.4%
现金及投资$530.00M
总负债$3.92B
净现金(净负债)-$3.39B
自由现金流/营收7.5%

利润表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
报告营业总收入 $1.37B $1.37B $4.72B $1.14B $1.14B
营业总收入 $1.37B $1.37B $4.72B $1.14B $1.14B
营业成本 $570.00M $586.00M $2.12B $555.00M $530.00M
毛利润 $798.00M $785.00M $2.59B $589.00M $607.00M
营业费用 $680.00M $616.00M $2.34B $570.00M $580.00M
销售及管理费用 $449.00M $381.00M $1.43B $338.00M $351.00M
研发费用 $92.00M $97.00M $368.00M $93.00M $89.00M
折旧、摊销与折耗 $139.00M $138.00M $543.00M $139.00M $140.00M
-折旧与摊销 $139.00M $138.00M $543.00M $139.00M $140.00M
营业利润 $118.00M $169.00M $252.00M $19.00M $27.00M
非经营性利息净收入(支出) -$59.00M -$57.00M -$220.00M -$80.00M -$52.00M
非经营性利息支出 $59.00M $57.00M $220.00M $80.00M $52.00M
其他收入(支出) -$3.00M -$25.00M -$256.00M -$198.00M -$25.00M
特殊收益(费用) -$9.00M -$16.00M -$237.00M -$202.00M -$25.00M
-减:重组及并购费用 $5.00M $14.00M $119.00M $116.00M $1.00M
-减:其他特殊支出 $4.00M $2.00M $8.00M $0.00 –
其他非经营性收入(支出) $6.00M -$9.00M -$19.00M $4.00M –
税前利润 $56.00M $87.00M -$224.00M -$259.00M -$50.00M
税费 $2.00M $30.00M $8.00M $17.00M -$16.00M
净利润 $54.00M $57.00M -$232.00M -$276.00M -$34.00M
持续经营利润 $54.00M $57.00M -$232.00M -$276.00M -$34.00M
归属母公司净利润 $54.00M $57.00M -$232.00M -$276.00M -$34.00M
归属普通股股东净利润 $54.00M $57.00M -$232.00M -$276.00M -$34.00M
基本每股收益 $0.11 $0.11 -$0.47 -$0.56 -$0.07
摊薄每股收益 $0.11 $0.11 -$0.47 -$0.56 -$0.07
-减:资本性资产减值 – – $71.00M $47.00M $24.00M
-减:核销 – – $39.00M – –
-业务出售收益 – – $0.00 $0.00 $0.00

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
总资产 $13.56B $13.22B $13.36B $13.36B $13.55B
流动资产合计 $3.80B $3.58B $3.46B $3.46B $3.49B
现金及现金等价物与短期投资 $530.00M $428.00M $545.00M $545.00M $505.00M
-现金及现金等价物 $530.00M $428.00M $545.00M $545.00M $505.00M
应收款 $1.15B $1.15B $940.00M $940.00M $975.00M
-应收账款 $1.08B $1.08B $873.00M $873.00M $894.00M
-其他应收款 $75.00M $70.00M $67.00M $67.00M $81.00M
存货 $1.77B $1.72B $1.74B $1.74B $1.71B
其他流动资产 $346.00M $285.00M $236.00M $236.00M $305.00M
非流动资产合计 $9.76B $9.64B $9.90B $9.90B $10.06B
固定资产净值 $1.41B $1.40B $1.41B $1.41B $1.39B
商誉及其他无形资产 $8.05B $7.95B $8.19B $8.19B $8.36B
-商誉 $4.85B $4.72B $4.78B $4.78B $4.76B
-其他无形资产 $3.20B $3.23B $3.41B $3.41B $3.60B
其他非流动资产 $304.00M $295.00M $304.00M $304.00M $306.00M
负债合计 $6.97B $6.72B $6.81B $6.81B $6.80B
流动负债合计 $1.85B $1.66B $1.60B $1.60B $1.46B
应付款 $427.00M $372.00M $368.00M $368.00M $352.00M
-应付账款 $427.00M $372.00M $368.00M $368.00M $352.00M
短期债务及融资租赁负债 $73.00M $73.00M $74.00M $74.00M $62.00M
-一年内到期债务 $73.00M $73.00M $74.00M $74.00M $62.00M
一年内递延负债 $450.00M $400.00M $416.00M $416.00M $376.00M
其他流动负债 $902.00M $817.00M $533.00M $533.00M $665.00M
非流动负债合计 $5.12B $5.06B $5.21B $5.21B $5.35B
长期债务及融资租赁负债 $3.85B $3.92B $3.94B $3.94B $3.96B
-长期债务 $3.85B $3.92B $3.94B $3.94B $3.96B
一年以上递延负债 $410.00M $366.00M $382.00M $382.00M $478.00M
其他非流动负债 $551.00M $467.00M $427.00M $427.00M $607.00M
股东权益合计 $6.59B $6.50B $6.55B $6.55B $6.75B
股东权益 $6.59B $6.50B $6.55B $6.55B $6.75B
股本 $0.00 $0.00 $0.00 $0.00 $0.00
-普通股 $0.00 $0.00 $0.00 $0.00 $0.00
-优先股 $0.00 $0.00 $0.00 $0.00 –
资本公积 $8.88B $8.86B $8.87B $8.87B $8.85B
留存收益 -$2.07B -$2.13B -$2.18B -$2.18B -$1.91B
不影响留存收益的损益 -$219.00M -$233.00M -$141.00M -$141.00M -$199.00M
-固定资产原值 – – $2.36B $2.36B –
-累计折旧 – – -$952.00M -$952.00M –
员工福利 – – $158.00M $158.00M –

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
经营活动现金流 $277.00M $13.00M $560.00M $108.00M $219.00M
持续经营经营活动现金流净额 $277.00M $13.00M $560.00M $108.00M $219.00M
持续经营净利润 $54.00M $57.00M -$232.00M -$276.00M -$34.00M
折旧、折耗与摊销 $171.00M $172.00M $680.00M $174.00M $176.00M
其他非现金项目 $8.00M $26.00M $8.00M $56.00M -$23.00M
营运资金变动 $24.00M -$263.00M $99.00M $225.00M $59.00M
投资活动现金流净额 -$110.00M -$60.00M -$279.00M -$64.00M -$101.00M
持续经营投资活动现金流净额 -$110.00M -$60.00M -$279.00M -$64.00M -$101.00M
固定资产购置及出售净额 -$33.00M -$51.00M -$276.00M -$62.00M -$92.00M
业务购买及出售净额 -$76.00M $0.00 $9.00M $0.00 $0.00
其他投资变动净额 -$1.00M -$9.00M -$12.00M -$2.00M -$9.00M
筹资活动现金流 -$74.00M -$65.00M -$275.00M -$18.00M -$153.00M
持续经营筹资活动现金流净额 -$74.00M -$65.00M -$275.00M -$18.00M -$153.00M
债务发行及偿还净额 -$73.00M -$16.00M -$563.00M -$1.00M -$188.00M
普通股发行净额 -$1.00M -$34.00M – – –
其他筹资费用净额 $0.00 -$15.00M $288.00M -$17.00M $21.00M
期末现金余额 $530.00M $428.00M $545.00M $545.00M $505.00M
现金净变动 $93.00M -$112.00M $6.00M $26.00M -$35.00M
期初现金余额 $428.00M $545.00M $468.00M $505.00M $539.00M
汇率变动影响 $9.00M -$5.00M $71.00M $14.00M $1.00M
自由现金流 $244.00M -$38.00M $284.00M $46.00M $127.00M
递延税款 – – -$134.00M – –
-应收款变动 – – -$12.00M – –
-存货变动 – – -$57.00M – –
-应付账款及应计费用变动 – – $147.00M – –
-其他流动资产变动 – – $21.00M – –

讨论区

暂无评论——快来第一个聊聊 ELAN。

登录后参与讨论。

Scroll to Top